已收盤 05-08 16:00:00 美东时间
-0.500
-2.82%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
华盛资讯5月6日讯,Flywire Corp.公布2026财年Q1业绩,公司Q1营收1.88亿美元,同比增长41.4%,归母净利润0.13亿美元,扭亏为盈。
05-06 19:51
BTIG analyst Andrew Harte maintains Flywire (NASDAQ:FLYW) with a Buy and raises the price target from $17 to $20.
05-06 18:59
U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, Lumentum Holdings and TransDigm Group, on Wednesday. HIGHLIGHTS * Advanced Micro Devices AMD.O : Ev
05-06 15:13
On Tuesday, Flywire (NASDAQ:FLYW) discussed first-quarter financial results dur...
05-06 06:22
Flywire (NASDAQ:FLYW) sees Q2 sales of $147.382 million-$154.876 million vs $153.418 million analyst estimate.
05-06 05:10
Flywire (NASDAQ:FLYW) raises FY2026 sales outlook from $693.565 million-$729.751 million to $711.658 million-$747.844 million vs $732.380 million estimate.
05-06 05:10
Flywire shares are trading higher after the company reported better-than-expect...
05-06 04:49
华盛资讯5月6日讯,Flywire Corp.公布2026财年Q1业绩,公司Q1营收1.88亿美元,同比增长41.0%,归母净利润0.13亿美元,扭亏为盈。
05-06 04:32